-
Jazz Pharma On Track To Report Top-Line, Late-Stage Results Of JZP-110 By December
Tuesday, May 17, 2016 - 4:11pm | 309Jazz Pharmaceuticals plc - Ordinary Shares (NASDAQ: JAZZ) "is well positioned to deliver a long-term EPS CAGR in at least the mid-to-high teens," according to a note from Piper Jaffray. Analyst David Amsellem noted that earnings growth will come from Xyrem, along with growing...
-
Market Wrap For March 31: Stocks Rally As Yellen Confirms Support For Economy
Monday, March 31, 2014 - 4:37pm | 2097U.S. stocks rose in the final day of the first quarter as the Fed's boss Janet Yellen said there is still room for the central bank to further boost the economy. Yellen, speaking in Chicago today, said the scars from the Great Recession remain, and reaching our goals will take time." Yellen...